Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Sanquin
Sponsor:
Information provided by (Responsible Party):
Sanquin
ClinicalTrials.gov Identifier:
NCT00892112
First received: May 1, 2009
Last updated: April 13, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2017
  Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)